İnterstisyel Sistit/Mesane Ağrı Sendromu

Nickel JC. Interstitial cystitis: a chronic pelvic pain syndrome. Medical Clinics. 2004;88(2):467-81.

Hanno PM. Bladder pain syndrome (interstitial cystitis) and related disorders. In: Wein AJ KL, Partin AW, Peters CA, editor. Campbell-Walsh Urology. 11th ed. Philadelphia,: Elsevier & Saunders; 2016. p. 357-401.

Clemens JQ, Meenan RT, O'Keeffe Rosetti MC, et al. Case-control study of medical comorbidities in women with interstitial cystitis. The Journal of urology. 2008;179(6):2222-5.

Moldwin RM, Hanno PM. Interstitial Cystitis/Bladder pain syndrome and related disorders. In: Partin AW DR, Kavoussi LR, Peters CA, editor. Campbell-Walsh-Wein Urology. 12th ed: Elsevier&Saunders; 2020.

Peters KM, Killinger KA, Ibrahim IA. Childhood symptoms and events in women with interstitial cystitis/painful bladder syndrome. Urology. 2009;73(2):258-62.

Rudick CN, Jiang M, Yaggie RE, et al. O-antigen modulates infection-induced pain states. 2012.

Evans R, Moldwin R, Cossons N, et al. Proof of concept trial of tanezumab for the treatment of symptoms associated with interstitial cystitis. The Journal of urology. 2011;185(5):1716-21.

Hang L, Wullt B, Shen Z, et al. Cytokine repertoire of epithelial cells lining the human urinary tract. The Journal of urology. 1998;159(6):2185-92.

Parsons CL, Bautista SL, Stein PC, et al. Cyto-injury factors in urine: a possible mechanism for the development of interstitial cystitis. The Journal of urology. 2000;164(4):1381-4.

Kelada E, Jones A. Interstitial cystitis. Archives of Gynecology and Obstetrics. 2007;275(4):223-9.

Van de Merwe JP, Nordling J, Bouchelouche P, et al. Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC proposal. European urology. 2008;53(1):60-7.

Fall M, Johansson SL, Aldenborg F. Chronic interstitial cystitis: a heterogeneous syndrome. The Journal of urology. 1987;137(1):35-8.

Warren JW, Brown J, Tracy JK, et al. Evidence-based criteria for pain of interstitial cystitis/painful bladder syndrome in women. Urology. 2008;71(3):444-8.

Malde S, Palmisani S, Al‐Kaisy A, et al. Guideline of guidelines: bladder pain syndrome. BJU international. 2018;122(5):729-43.

Parsons CL, Stein PC, Bidair M, et al. Abnormal sensitivity to intravesical potassium in interstitial cystitis and radiation cystitis. Neurourology and urodynamics. 1994;13(5):515-20.

Keay SK, Zhang C-O, Shoenfelt J, et al. Sensitivity and specificity of antiproliferative factor, heparin-binding epidermal growth factor–like growth factor, and epidermal growth factor as urine markers for interstitial cystitis. Urology. 2001;57(6):9-14.

Evans RJ, Sant GR. Current diagnosis of interstitial cystitis: an evolving paradigm. Urology. 2007;69(4):S64-S72.

Denson MA, Griebling TL, Cohen MB, et al. Comparison of cystoscopic and histological findings in patients with suspected interstitial cystitis. The Journal of urology. 2000;164(6):1908-11.

Ottem DP, Teichman JM. What is the value of cystoscopy with hydrodistension for interstitial cystitis? Urology. 2005;66(3):494-9.

Sant G, Propert K, Hanno P, et al. A pilot clinical trial of oral pentosan polysulfate and oral hydroxyzine in patients with interstitial cystitis. The Journal of urology. 2003;170(3):810-5.

Peeker R, Fall M. Toward a precise definition of interstitial cystitis: further evidence of differences in classic and nonulcer disease. The Journal of urology. 2002;167(6):2470-2.

Sant GR. Etiology, pathogenesis, and diagnosis of interstitial cystitis. Reviews in urology. 2002;4(Suppl 1):S9.

Chaiken DC, Blaivas JG, Blaivas ST. Behavioral therapy for the treatment of refractory interstitial cystitis. The Journal of urology. 1993;149(6):1445-8.

van Ophoven A, Heinecke A, Hertle L. Safety and efficacy of concurrent application of oral pentosan polysulfate and subcutaneous low-dose heparin for patients with interstitial cystitis. Urology. 2005;66(4):707-11.

Fritjofsson Å, Fall M, Juhlin R, et al. Treatment of ulcer and nonulcer interstitial cystitis with sodium pentosanpolysulfate: a multicenter trial. The Journal of urology. 1987;138(3):508-12.

Hanif AM, Armenti ST, Taylor SC, et al. Phenotypic spectrum of pentosan polysulfate sodium–associated maculopathy: a multicenter study. JAMA ophthalmology. 2019;137(11):1275-82.

van Ophoven A, Pokupic S, Heinecke A, et al. A prospective, randomized, placebo controlled, double-blind study of amitriptyline for the treatment of interstitial cystitis. J Urol. 2004;172(2):533-6.

Thilagarajah R, Witherow RO, Walker MM. Oral cimetidine gives effective symptom relief in painful bladder disease: a prospective, randomized, double-blind placebo-controlled trial. BJU Int. 2001;87(3):207-12.

Barua JM, Arance I, Angulo JC, et al. A systematic review and meta-analysis on the efficacy of intravesical therapy for bladder pain syndrome/interstitial cystitis. Int Urogynecol J. 2016;27(8):1137-47.

Sant GR, LaRock DR. Standard intravesical therapies for interstitial cystitis. Urol Clin North Am. 1994;21(1):73-83.

Nickel JC, Moldwin R, Lee S, et al. Intravesical alkalinized lidocaine (PSD597) offers sustained relief from symptoms of interstitial cystitis and painful bladder syndrome. BJU Int. 2009;103(7):910-8.

Pyo JS, Cho WJ. Systematic Review and Meta-Analysis of Intravesical Hyaluronic Acid and Hyaluronic Acid/Chondroitin Sulfate Instillation for Interstitial Cystitis/Painful Bladder Syndrome. Cell Physiol Biochem. 2016;39(4):1618-25.

Parsons CL, Housley T, Schmidt JD, et al. Treatment of interstitial cystitis with intravesical heparin. Br J Urol. 1994;73(5):504-7.

Pinto R, Lopes T, Frias B, et al. Trigonal injection of botulinum toxin A in patients with refractory bladder pain syndrome/interstitial cystitis. Eur Urol. 2010;58(3):360-5.

Engeler D, Baranowski A, Borovicka J, et al. EAU Guidelines, Full Text, Chronic Pelvic Pain 2018. European Association of Urology. Daniel Engeler, AP Baranowski, J. Borovicka, AQ Cottrell, P Dinis- Oliveira, S. Elneil, J Hughes, Bert Messelink, AC De Williams. Guidelines Associates: B Parsons, S Goonewardene. 2018.

Kim HJ, Lee JS, Cho WJ, et al. Efficacy and safety of augmentation ileocystoplasty combined with supratrigonal cystectomy for the treatment of refractory bladder pain syndrome/interstitial cystitis with Hunner's lesion. Int J Urol. 2014;21 Suppl 1:69-73.

Comiter CV. Sacral neuromodulation for the symptomatic treatment of refractory interstitial cystitis: a prospective study. J Urol. 2003;169(4):1369-73.

Tyagi P, Wu PC, Chancellor M, et al. Recent advances in intravesical drug/gene delivery. Mol Pharm. 2006;3(4):369-79.

Nickel JC. Interstitial cystitis: a chronic pelvic pain syndrome. Medical Clinics. 2004;88(2):467-81.

Hanno PM. Bladder pain syndrome (interstitial cystitis) and related disorders. In: Wein AJ KL, Partin AW, Peters CA, editor. Campbell-Walsh Urology. 11th ed. Philadelphia,: Elsevier & Saunders; 2016. p. 357-401.

Clemens JQ, Meenan RT, O'Keeffe Rosetti MC, et al. Case-control study of medical comorbidities in women with interstitial cystitis. The Journal of urology. 2008;179(6):2222-5.

Moldwin RM, Hanno PM. Interstitial Cystitis/Bladder pain syndrome and related disorders. In: Partin AW DR, Kavoussi LR, Peters CA, editor. Campbell-Walsh-Wein Urology. 12th ed: Elsevier&Saunders; 2020.

Peters KM, Killinger KA, Ibrahim IA. Childhood symptoms and events in women with interstitial cystitis/painful bladder syndrome. Urology. 2009;73(2):258-62.

Rudick CN, Jiang M, Yaggie RE, et al. O-antigen modulates infection-induced pain states. 2012.

Evans R, Moldwin R, Cossons N, et al. Proof of concept trial of tanezumab for the treatment of symptoms associated with interstitial cystitis. The Journal of urology. 2011;185(5):1716-21.

Hang L, Wullt B, Shen Z, et al. Cytokine repertoire of epithelial cells lining the human urinary tract. The Journal of urology. 1998;159(6):2185-92.

Parsons CL, Bautista SL, Stein PC, et al. Cyto-injury factors in urine: a possible mechanism for the development of interstitial cystitis. The Journal of urology. 2000;164(4):1381-4.

Kelada E, Jones A. Interstitial cystitis. Archives of Gynecology and Obstetrics. 2007;275(4):223-9.

Van de Merwe JP, Nordling J, Bouchelouche P, et al. Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC proposal. European urology. 2008;53(1):60-7.

Fall M, Johansson SL, Aldenborg F. Chronic interstitial cystitis: a heterogeneous syndrome. The Journal of urology. 1987;137(1):35-8.

Warren JW, Brown J, Tracy JK, et al. Evidence-based criteria for pain of interstitial cystitis/painful bladder syndrome in women. Urology. 2008;71(3):444-8.

Malde S, Palmisani S, Al‐Kaisy A, et al. Guideline of guidelines: bladder pain syndrome. BJU international. 2018;122(5):729-43.

Parsons CL, Stein PC, Bidair M, et al. Abnormal sensitivity to intravesical potassium in interstitial cystitis and radiation cystitis. Neurourology and urodynamics. 1994;13(5):515-20.

Keay SK, Zhang C-O, Shoenfelt J, et al. Sensitivity and specificity of antiproliferative factor, heparin-binding epidermal growth factor–like growth factor, and epidermal growth factor as urine markers for interstitial cystitis. Urology. 2001;57(6):9-14.

Evans RJ, Sant GR. Current diagnosis of interstitial cystitis: an evolving paradigm. Urology. 2007;69(4):S64-S72.

Denson MA, Griebling TL, Cohen MB, et al. Comparison of cystoscopic and histological findings in patients with suspected interstitial cystitis. The Journal of urology. 2000;164(6):1908-11.

Ottem DP, Teichman JM. What is the value of cystoscopy with hydrodistension for interstitial cystitis? Urology. 2005;66(3):494-9.

Sant G, Propert K, Hanno P, et al. A pilot clinical trial of oral pentosan polysulfate and oral hydroxyzine in patients with interstitial cystitis. The Journal of urology. 2003;170(3):810-5.

Peeker R, Fall M. Toward a precise definition of interstitial cystitis: further evidence of differences in classic and nonulcer disease. The Journal of urology. 2002;167(6):2470-2.

Sant GR. Etiology, pathogenesis, and diagnosis of interstitial cystitis. Reviews in urology. 2002;4(Suppl 1):S9.

Chaiken DC, Blaivas JG, Blaivas ST. Behavioral therapy for the treatment of refractory interstitial cystitis. The Journal of urology. 1993;149(6):1445-8.

van Ophoven A, Heinecke A, Hertle L. Safety and efficacy of concurrent application of oral pentosan polysulfate and subcutaneous low-dose heparin for patients with interstitial cystitis. Urology. 2005;66(4):707-11.

Fritjofsson Å, Fall M, Juhlin R, et al. Treatment of ulcer and nonulcer interstitial cystitis with sodium pentosanpolysulfate: a multicenter trial. The Journal of urology. 1987;138(3):508-12.

Hanif AM, Armenti ST, Taylor SC, et al. Phenotypic spectrum of pentosan polysulfate sodium–associated maculopathy: a multicenter study. JAMA ophthalmology. 2019;137(11):1275-82.

van Ophoven A, Pokupic S, Heinecke A, et al. A prospective, randomized, placebo controlled, double-blind study of amitriptyline for the treatment of interstitial cystitis. J Urol. 2004;172(2):533-6.

Thilagarajah R, Witherow RO, Walker MM. Oral cimetidine gives effective symptom relief in painful bladder disease: a prospective, randomized, double-blind placebo-controlled trial. BJU Int. 2001;87(3):207-12.

Barua JM, Arance I, Angulo JC, et al. A systematic review and meta-analysis on the efficacy of intravesical therapy for bladder pain syndrome/interstitial cystitis. Int Urogynecol J. 2016;27(8):1137-47.

Sant GR, LaRock DR. Standard intravesical therapies for interstitial cystitis. Urol Clin North Am. 1994;21(1):73-83.

Nickel JC, Moldwin R, Lee S, et al. Intravesical alkalinized lidocaine (PSD597) offers sustained relief from symptoms of interstitial cystitis and painful bladder syndrome. BJU Int. 2009;103(7):910-8.

Pyo JS, Cho WJ. Systematic Review and Meta-Analysis of Intravesical Hyaluronic Acid and Hyaluronic Acid/Chondroitin Sulfate Instillation for Interstitial Cystitis/Painful Bladder Syndrome. Cell Physiol Biochem. 2016;39(4):1618-25.

Parsons CL, Housley T, Schmidt JD, et al. Treatment of interstitial cystitis with intravesical heparin. Br J Urol. 1994;73(5):504-7.

Pinto R, Lopes T, Frias B, et al. Trigonal injection of botulinum toxin A in patients with refractory bladder pain syndrome/interstitial cystitis. Eur Urol. 2010;58(3):360-5.

Engeler D, Baranowski A, Borovicka J, et al. EAU Guidelines, Full Text, Chronic Pelvic Pain 2018. European Association of Urology. Daniel Engeler, AP Baranowski, J. Borovicka, AQ Cottrell, P Dinis- Oliveira, S. Elneil, J Hughes, Bert Messelink, AC De Williams. Guidelines Associates: B Parsons, S Goonewardene. 2018.

Kim HJ, Lee JS, Cho WJ, et al. Efficacy and safety of augmentation ileocystoplasty combined with supratrigonal cystectomy for the treatment of refractory bladder pain syndrome/interstitial cystitis with Hunner's lesion. Int J Urol. 2014;21 Suppl 1:69-73.

Comiter CV. Sacral neuromodulation for the symptomatic treatment of refractory interstitial cystitis: a prospective study. J Urol. 2003;169(4):1369-73.

Tyagi P, Wu PC, Chancellor M, et al. Recent advances in intravesical drug/gene delivery. Mol Pharm. 2006;3(4):369-79.